Richard Kivel - Net Worth and Insider Trading
Richard Kivel Net Worth
The estimated net worth of Richard Kivel is at least $36 dollars as of 2024-04-19. Richard Kivel is the Director of Rexahn Pharmaceuticals Inc and owns about 5 shares of Rexahn Pharmaceuticals Inc (REXN) stock worth over $36. Details can be seen in Richard Kivel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Kivel has not made any transactions after 2011-10-03 and currently still holds the listed stock(s).
Transaction Summary of Richard Kivel
Richard Kivel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Kivel owns 3 companies in total, including Rexahn Pharmaceuticals Inc () , Ocuphire Pharma Inc () , and Lottery.com Inc () .
Click here to see the complete history of Richard Kivel’s form 4 insider trades.
Insider Ownership Summary of Richard Kivel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Rexahn Pharmaceuticals Inc | 2012-06-18 | director | |
| Ocuphire Pharma Inc | 2010-09-13 | director | |
| Lottery.com Inc | 2021-10-29 | director |
Richard Kivel Latest Holdings Summary
Richard Kivel currently owns a total of 1 stock. Richard Kivel owns 5 shares of Rexahn Pharmaceuticals Inc (REXN) as of October 3, 2011, with a value of $36.
Latest Holdings of Richard Kivel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REXN | Rexahn Pharmaceuticals Inc | 2011-10-03 | 5 | 7.24 | 36 |
Holding Weightings of Richard Kivel
Richard Kivel Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Kivel has made a total of 0 transactions in Rexahn Pharmaceuticals Inc (REXN) over the past 5 years. The most-recent trade in Rexahn Pharmaceuticals Inc is the acquisition of 5 shares on October 3, 2011, which cost Richard Kivel around $2,600.
Insider Trading History of Richard Kivel
- 1
Richard Kivel Trading Performance
GuruFocus tracks the stock performance after each of Richard Kivel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Kivel is -59.18%. GuruFocus also compares Richard Kivel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Kivel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Kivel's insider trading performs compared to the benchmark.
Performance of Richard Kivel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.08 | -59.18 | -47.96 | -47.87 | -28.18 | -8.11 |
| Relative Return to S&P 500(%) | -10.65 | -75.36 | -76.54 | -79.77 | -51.72 | -29.51 |
Richard Kivel Ownership Network
Ownership Network List of Richard Kivel
Ownership Network Relation of Richard Kivel
Richard Kivel Owned Company Details
What does Rexahn Pharmaceuticals Inc do?
Who are the key executives at Rexahn Pharmaceuticals Inc?
Richard Kivel is the director of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .
Rexahn Pharmaceuticals Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rexahn Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Rexahn Pharmaceuticals Inc Insider Transactions
Richard Kivel Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Kivel. You might contact Richard Kivel via mailing address: C/o Rexahn Pharmaceuticals, Inc., 15245 Shady Grove Road, Suite 455, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
